| dc.contributor |
University of Aberdeen.Medical Sciences |
|
| dc.contributor |
University of Aberdeen.Clinical Medicine |
|
| dc.contributor |
University of Aberdeen.Institute of Medical Sciences |
|
| dc.creator |
Langlands, Fiona E. |
|
| dc.creator |
Dodwell, David |
|
| dc.creator |
Hanby, Andrew M. |
|
| dc.creator |
Horgan, Kieran |
|
| dc.creator |
Millican-Slater, Rebecca A. |
|
| dc.creator |
Speirs, Valerie |
|
| dc.creator |
Verghese, Eldo T. |
|
| dc.creator |
Smith, Laura |
|
| dc.creator |
Hughes, Thomas A. |
|
| dc.date |
2018-07-26T23:02:41Z |
|
| dc.date |
2018-07-26T23:02:41Z |
|
| dc.date |
2014-03-28 |
|
| dc.date.accessioned |
2022-05-24T06:08:41Z |
|
| dc.date.available |
2022-05-24T06:08:41Z |
|
| dc.identifier |
Langlands , F E , Dodwell , D , Hanby , A M , Horgan , K , Millican-Slater , R A , Speirs , V , Verghese , E T , Smith , L & Hughes , T A 2014 , ' PSMD9 expression predicts radiotherapy response in breast cancer ' , Molecular Cancer , vol. 13 , 73 . https://doi.org/10.1186/1476-4598-13-73 |
|
| dc.identifier |
1476-4598 |
|
| dc.identifier |
PURE: 129547769 |
|
| dc.identifier |
PURE UUID: a2ed0006-cf81-4a12-a436-d926b8b74cae |
|
| dc.identifier |
PubMed: 24673853 |
|
| dc.identifier |
PubMedCentral: PMC4230020 |
|
| dc.identifier |
Scopus: 84901245817 |
|
| dc.identifier |
ORCID: /0000-0002-0602-4666/work/72631199 |
|
| dc.identifier |
http://hdl.handle.net/2164/10813 |
|
| dc.identifier |
https://doi.org/10.1186/1476-4598-13-73 |
|
| dc.identifier |
13 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/117795 |
|
| dc.description |
This work was supported by the Breast Cancer Campaign (FEL, LS, VS, TAH), the Breast Cancer Research Action Group (TAH), and the Medical Research Council (ETV). The funders had no roles in designing or carrying out the research, or in preparing the manuscript. |
|
| dc.description |
Peer reviewed |
|
| dc.description |
Publisher PDF |
|
| dc.format |
8 |
|
| dc.format |
application/pdf |
|
| dc.language |
eng |
|
| dc.relation |
Molecular Cancer |
|
| dc.rights |
© Langlands et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
|
| dc.subject |
SDG 3 - Good Health and Well-being |
|
| dc.subject |
predictive marker |
|
| dc.subject |
radiotherapy |
|
| dc.subject |
proteasome |
|
| dc.subject |
RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
|
| dc.subject |
Medical Research Council (MRC) |
|
| dc.subject |
RC0254 |
|
| dc.title |
PSMD9 expression predicts radiotherapy response in breast cancer |
|
| dc.type |
Journal article |
|